Keyphrases
Systemic Sclerosis
100%
Hematopoietic Stem Cell Transplantation
100%
Autologous Hematopoietic Stem Cell
85%
Hematopoietic Stem Cell Therapy
85%
Immunosuppressive Therapy
28%
Autoimmune Disease
28%
Clinical Trials
14%
Stem Cell Transplantation
14%
Unanswered Questions
14%
Quality of Life
14%
Severe Disease
14%
High Mortality
14%
Multisystem
14%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
14%
Non-infectious
14%
Randomized Controlled Clinical Trial
14%
Treatment Toxicity
14%
Serious Adverse Events
14%
Disease Relapse
14%
Transplant-related Mortality
14%
Registry Study
14%
Skin Involvement
14%
Treatment-related Mortality
14%
Intravenous Cyclophosphamide
14%
Medicine and Dentistry
Hematopoietic Stem Cell Transplantation
100%
Systemic Scleroderma
100%
Immunosuppressive Treatment
28%
Autoimmune Disease
28%
Adverse Event
14%
Cyclophosphamide
14%
Stem Cell Therapy
14%
Controlled Clinical Trial
14%
Stem Cell Transplant
14%
Clinical Trial
14%
Quality of Life
14%
Diseases
14%
Immunology and Microbiology
Systemic Scleroderma
100%
Hematopoietic Stem Cell Transplantation
100%
Immunosuppressive Therapy
28%
Autoimmune Disease
28%
Stem Cell Transplant
14%
Stem Cell Transplantation
14%
Cyclophosphamide
14%
Pharmacology, Toxicology and Pharmaceutical Science
Systemic Sclerosis
100%
Immunosuppressive Agent
28%
Autoimmune Disease
28%
Controlled Clinical Trial
14%
Clinical Trial
14%
Adverse Event
14%
Cyclophosphamide
14%
Diseases
14%